Recurrent Malignant Solid Neoplasm

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08916Afatinib1Recruiting1
DB08885Aflibercept1Recruiting1
DB08875Cabozantinib1Active Not Recruiting1
DB08875Cabozantinib1Recruiting1
DB01101Capecitabine1Recruiting1
DB08912Dabrafenib1Recruiting1
DB00762Irinotecan1Recruiting1
DB12340Navitoclax1Recruiting1
DB09035Nivolumab1Recruiting1
DB06306Onalespib1Recruiting1
DB09037Pembrolizumab1Recruiting1
DB11759Pevonedistat1Recruiting1
DB06176Romidepsin1Recruiting1
DB11836Sapanisertib1Recruiting1
DB00398Sorafenib1Recruiting1
DB00853Temozolomide1Recruiting1
DB08911Trametinib1Recruiting1
DB00515Cisplatin1 / 2Recruiting1
DB06186Ipilimumab1 / 2Recruiting1
DB00762Irinotecan1 / 2Recruiting1
DB11740MK-17751 / 2Recruiting1
DB06328Methoxyamine1 / 2Recruiting1
DB12340Navitoclax1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB00642Pemetrexed1 / 2Recruiting1
DB12257Platinum1 / 2Recruiting1
DB11760Talazoparib1 / 2Suspended1
DB00853Temozolomide1 / 2Suspended1
DB08911Trametinib1 / 2Recruiting1
DB11925Vistusertib1 / 2Suspended1
DB08916Afatinib2Recruiting1
DB08875Cabozantinib2Recruiting1
DB00958Carboplatin2Suspended1
DB08865Crizotinib2Recruiting1
DB08912Dabrafenib2Recruiting1
DB01254Dasatinib2Recruiting1
DB12147Erdafitinib2Recruiting1
DB01590Everolimus2Suspended1
DB12167LY-30234142Recruiting1
DB11740MK-17752Suspended1
DB09035Nivolumab2Recruiting1
DB09074Olaparib2Recruiting3
DB09330Osimertinib2Recruiting1
DB09073Palbociclib2Recruiting2
DB09037Pembrolizumab2Recruiting1
DB06366Pertuzumab2Recruiting1
DB11836Sapanisertib2Recruiting1
DB11689Selumetinib2Recruiting1
DB01268Sunitinib2Recruiting1
DB12887Tazemetostat2Suspended1
DB00853Temozolomide2Suspended1
DB08911Trametinib2Recruiting1
DB08911Trametinib2Suspended1
DB00072Trastuzumab2Recruiting1
DB05773Trastuzumab emtansine2Recruiting1
DB07232Veliparib2Suspended1
DB08881Vemurafenib2Recruiting2
DB08828Vismodegib2Recruiting1
DB13104X-3962Recruiting2